HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jessica Vermeulen Selected Research

Agammaglobulinaemia Tyrosine Kinase

10/2018Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study.
10/2017Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials.
8/2014Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jessica Vermeulen Research Topics

Disease

10Multiple Myeloma
04/2023 - 01/2019
10Neoplasms (Cancer)
04/2023 - 09/2011
6Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2023 - 08/2014
6Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2022 - 02/2016
4Amyloidosis
11/2022 - 01/2021
4Lymphopenia (Lymphocytopenia)
11/2021 - 10/2015
3Immunoglobulin Light-chain Amyloidosis
12/2023 - 01/2020
3Pneumonia (Pneumonitis)
11/2021 - 01/2021
3Neutropenia
11/2021 - 01/2021
3Multi-centric Castleman's Disease
11/2017 - 08/2014
3Lymphoproliferative Disorders (Lymphoproliferative Disorder)
10/2015 - 08/2014
2Lymphoma (Lymphomas)
01/2023 - 12/2017
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022 - 10/2018
2Disease Progression
10/2021 - 01/2021
2Hypertension (High Blood Pressure)
10/2021 - 10/2018
2Respiratory Tract Infections (Respiratory Tract Infection)
01/2021 - 08/2014
2Diarrhea
01/2021 - 10/2018
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2018 - 10/2017
2Atrial Fibrillation
10/2018 - 10/2017
2Rheumatoid Arthritis
11/2017 - 10/2015
2Castleman Disease (Castleman's Disease)
10/2015 - 10/2015
1Rare Diseases (Rare Disease)
12/2023
1Thrombosis (Thrombus)
11/2022
1Septic Shock (Toxic Shock Syndrome)
10/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2021
1Cardiomyopathies (Cardiomyopathy)
01/2021
1Thrombocytopenia (Thrombopenia)
01/2021
1Heart Failure
01/2021
1Inflammation (Inflammations)
01/2021
1Anhedonia
11/2017
1B-Cell Lymphoma (Lymphoma, B Cell)
11/2017
1Major Depressive Disorder (Major Depressive Disorders)
11/2017
1Leukopenia
10/2015
1Infections
10/2015
1Hypertriglyceridemia
10/2015
1Hypercholesterolemia
10/2015
1Polycythemia (Erythrocytosis)
10/2015
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2015
1Anemia
10/2015
1Fatigue
04/2015
1Chronic Disease (Chronic Diseases)
04/2015
1Pain (Aches)
04/2015
1Sepsis (Septicemia)
08/2014
1Anaphylaxis (Anaphylactic Shock)
08/2014
1Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2014
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2014
1Ovarian Neoplasms (Ovarian Cancer)
09/2011

Drug/Important Bio-Agent (IBA)

13ibrutinibIBA
11/2022 - 08/2014
12daratumumabIBA
04/2023 - 01/2019
12Dexamethasone (Maxidex)FDA LinkGeneric
04/2023 - 01/2019
10Bortezomib (Velcade)FDA Link
11/2022 - 01/2019
8Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2022 - 08/2014
7Interleukin-6 (Interleukin 6)IBA
11/2017 - 09/2011
6Lenalidomide (CC 5013)FDA Link
04/2023 - 01/2020
6siltuximabIBA
10/2015 - 09/2011
5Rituximab (Mabthera)FDA Link
11/2022 - 08/2014
5Monoclonal AntibodiesIBA
11/2017 - 04/2014
4Amyloid (Amyloid Fibrils)IBA
12/2023 - 01/2021
4Prednisone (Sone)FDA LinkGeneric
11/2022 - 08/2014
4Vincristine (Oncovin)FDA LinkGeneric
11/2022 - 08/2014
4Doxorubicin (Adriamycin)FDA LinkGeneric
11/2022 - 08/2014
3temsirolimusFDA Link
10/2022 - 02/2016
3Thalidomide (Thalomid)FDA Link
10/2021 - 01/2019
3Agammaglobulinaemia Tyrosine KinaseIBA
10/2018 - 08/2014
3InterleukinsIBA
10/2015 - 04/2014
2Indicators and Reagents (Reagents)IBA
12/2023 - 01/2023
2Proteins (Proteins, Gene)FDA Link
04/2023 - 01/2023
2CytokinesIBA
11/2017 - 09/2011
1vinyltriethoxysilane (VTES)IBA
11/2022
1Proteasome InhibitorsIBA
01/2021
1Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
01/2021
1pomalidomideIBA
01/2021
1carboxyl radical (COO-)IBA
01/2021
1Neutralizing AntibodiesIBA
11/2017
1CholesterolIBA
10/2015
1HepcidinsIBA
10/2015
1Biomarkers (Surrogate Marker)IBA
10/2015
1ErbB Receptors (EGF Receptor)IBA
04/2014
1ChemokinesIBA
09/2011
1PlatinumIBA
09/2011

Therapy/Procedure

10Therapeutics
12/2023 - 08/2014
4Stem Cell Transplantation
11/2022 - 01/2019
2Transplantation
11/2021 - 01/2021
1Drug Therapy (Chemotherapy)
11/2021